Nanoformulations for molecular MRI

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 4, Issue 4, 2012, Pages 448-457

  Tu, Chuqiao ^a   Louie, Angelique Y ^a  

^a University of California Davis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; CLINICAL USE; CONTRAST AGENT; DETECTION SENSITIVITY; IRON OXIDE NANOPARTICLE; MOLECULAR SIGNATURES; NANO PARTICULATES; NANO SCALE; ORDERS OF MAGNITUDE;

COBALT; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MANGANESE; METAL IONS;

MOLECULAR IMAGING;

CLIAVIST; COBALT; COPPER ION; FERUCARBOTRAN; FERUMOXSIL; FERUMOXYTOL; GADOLINIUM; IRON OXIDE; MANGANESE; NANOPARTICLE; NICKEL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYAMIDOAMINE; SUPERPARAMAGNETIC IRON OXIDE; TETRAXETAN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; MAGNETISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; METALS; MOLECULAR IMAGING; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 84862647051     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1170     Document Type: Article

References (57)

1. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99:2293-2352.
2. Burtea C, Laurent S, Elst LV, Muller RN. Contrast agents: magnetic resonance. In: Semmler W, Schwaiger M, eds. Molecular Imaging I: Handbook of Experimental Pharmacology. Heidelberg: Springer-Verlag Berlin; 2008, 135-165.
3. Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A. Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:299-310.
4. Tu C, Louie AY. Nanobiomaterials for dual-mode molecular imaging: advances in probes for MR/optical imaging applications. In: Sitharaman B, ed. Nanobiomaterials Handbook. Boca Raton: CRC Press/Taylor & Francis Group; 2011, 1-29.
5. Bui T, Stevenson J, Hoekman J, Zhang SR, Maravilla K, Ho RJY. Novel GD nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging. PLoS One 2010, 5:e13082.
6. Villaraza AJL, Bumb A, Brechbiel MW. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 2010, 110:2921-2959.
7. Na HB, Hyeon T. Nanostructured T1 MRI contrast agents. J Mater Chem 2009, 19:6267-6273.
8. Bumb A, Brechbiel MW, Choyke P. Macromolecular and dendrimer-based magnetic resonance contrast agents. Acta Radiol 2010, 51:751-767.
9. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 2008, 3:703-717.
10. Thorek DLJ, Chen A, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006, 34:23-38.
11. Chen W, Cormode DP, Fayad ZA, Mulder WJM. Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:146-161.
12. Morishige K, Kacher DF, Libby P, Josephson L, Ganz P, Weissleder R, Aikawa M. High-Resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation 2010, 122:1707-1715.
13. Shen T, Weissleder R, Papisov M, Bogdanov A, Brady TJ. Monocrystalline iron-oxide nanocompounds (MION) - physicochemical properties. Magn Reson Med 1993, 29:599-604.
14. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010, 74:213-220.
15. de Winther MPJ, van Dijk KW, Havekes LM, Hofker MH. Macrophage scavenger receptor class A - a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:290-297.
16. Jarrett BR, Correa C, Ma KL, Louie AY. In Vivo Mapping of Vascular Inflammation Using Multimodal Imaging. PLoS One 2010, 5:e13254.
17. Jarrett BR, Frendo M, Vogan J, Louie AY. Size-controlled synthesis of dextran sulfate coated iron oxide nanoparticles for magnetic resonance imaging. Nanotechnology 2007, 18:035603.
18. Jarrett BR, Gustafsson B, Kukis DL, Louie AY. Synthesis of Cu-64-labeled magnetic nanoparticles for multimodal imaging. Bioconjug Chem 2008, 19:1496-1504.
19. Tu C, Ng TSC, Sohi HK, Palko HA, House A, Jacobs RE, Louie AY. Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques. Biomaterials 2011, 32:7209-7216.
20. Berman SMC, Walczak P, Bulte JWM. Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:343-355.
21. Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, Journeay WS, Subramani K, Laurent S. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev 2011, 111:253-280.
22. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, Frank JA. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005, 105:420-425.
23. Neri M, Maderna C, Cavazzin C, Deidda-Vigoriti V, Politi LS, Scotti G, Marzola P, Sbarbati A, Vescovi AL, Gritti A. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells 2008, 26:505-516.
24. Cormode DP, Skajaa T, Fayad ZA, Mulder WJM. Nanotechnology in medical imaging probe design and applications. Arterioscler Thromb Vasc Biol 2009, 29:992-1000.
25. Hermann P, Kotek J, Kubicek V, Lukes I. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Dalton Trans 2008:3027-3047.
26. Sharma P, Brown SC, Walter G, Santra S, Scott E, Ichikawa H, Fukumori Y, Moudgil BM. GD nanoparticulates: from magnetic resonance imaging to neutron capture therapy. Adv Powder Technol 2007, 663-698.
27. Mody VV, Nounou MI, Bikram M. Novel nanomedicine-based MRI contrast agents for gynecological malignancies. Adv Drug Deliv Rev 2009, 61:795-807.
28. Shao YZ, Liu LZ, Song SQ, Cao RH, Liu H, Cui CY, Li X, Bie M-j, Li L. A novel one-step synthesis of Gd(3+)-incorporated mesoporous SiO(2) nanoparticles for use as an efficient MRI contrast agent. Contrast Media Mol Imaging 2011, 6:110-118.
29. Barrett T, Ravizzini G, Choyke PL, Kobayashi H. Dendrimers in medical nanotechnology application of dendrimer molecules in bioimaging and cancer treatment. IEEE Eng Med Biol Mag 2009, 28:12-22.
30. Bosman AW, Janssen HM, Meijer EW. About dendrimers: structure, physical properties, and applications. Chem Rev 1999, 99:1665-1688.
31. Swanson SD, Kukowska-Latallo JF, Patri AK, Chen CY, Ge S, Cao ZY, Kotlyar A, East AT, Baker JR. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int J Nanomed 2008, 3:201-210.
32. Kaneshiro TL, Jeong EK, Morrell G, Parker DL, Lu ZR. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography. Biomacromolecules 2008, 9:2742-2748.
33. Nwe K, Bryant LH, Brechbiel MW. Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques. Bioconjug Chem 2010, 21:1014-1017.
34. Bryant LH, Brechbiel MW, Wu CC, Bulte JWM, Herynek V, Frank JA. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging 1999, 9:348-352.
35. Nwe K, Milenic D, Bryant LH, Regino CAS, Brechbiel MW. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI. J Inorg Biochem 2011, 105:722-727.
36. Luo K, Liu G, She WC, Wang QY, Wang G, He B, Ai H, Gong Q, Song B, Gu Z. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents. Biomaterials 2011, 32:7951-7960.
37. Matson ML, Wilson LJ. Nanotechnology and MRI contrast enhancement. Future Med Chem 2010, 2:491-502.
38. Bolskar RD. Gadofullerene MRI contrast agents. Nanomedicine 2008, 3:201-213.
39. Zhang JF, Fatouros PP, Shu CY, Reid J, Owens LS, Cai T, Gibson HW, Long GL, Corwin FD, Chen Z-J, et al. High relaxivity trimetallic nitride (Gd(3)N) metallofullerene MRI contrast agents with optimized functionality. Bioconjug Chem 2010, 21:610-615.
40. Fatouros PP, Corwin FD, Chen ZJ, Broaddus WC, Tatum JL, Kettenmann B, Ge Z, Gibson HW, Russ JL, Leonard AP, et al. In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology 2006, 240:756-764.
41. Shultz MD, Wilson JD, Fuller CE, Zhang JY, Dorn HC, Fatouros PP. Metallofullerene-based nanoplatform for brain tumor brachytherapy and longitudinal imaging in a murine orthotopic xenograft model. Radiology 2011, 261:136-143.
42. Stevenson S, Stephen RR, Amos TM, Cadorette VR, Reid JE, Phillips JP. Synthesis and purification of a metallic nitride fullerene BisAdduct: Exploring the reactivity of Gd3N@C-80. J Am Chem Soc 2005, 127:12776-12777.
43. Sitharaman B, Kissell KR, Hartman KB, Tran LA, Baikalov A, Rusakova I, Sun Y, Khant HA, Ludtke SJ, Chiu W, et al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun 2005:3915-3917.
44. Hartman KB, Laus S, Bolskar RD, Muthupillai R, Helm L, Toth E, Merbach AE, Wilson LJ. Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. Nano Lett 2008, 8:415-419.
45. Tran LA, Krishnamurthy R, Muthupillai R, Cabreira-Hansen MD, Willerson JT, Perin EC, Wilson LJ. Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials 2010, 31:9482-9491.
46. Hassan AA, Chan BTY, Tran LA, Hartman KB, Ananta JS, Mackeyev Y, Hu L, Pautler RG, Wilson LJ, Lee AV. Serine-derivatized gadonanotubes as magnetic nanoprobes for intracellular labeling. Contrast Media Mol Imaging 2010, 5:34-38.
47. Mackeyev Y, Hartman KB, Ananta JS, Lee AV, Wilson LJ. Catalytic synthesis of amino acid and peptide derivatized gadonanotubes. J Am Chem Soc 2009, 131:8342.
48. Lee JH, Huh YM, Jun Y, Seo J, Jang J, Song HT, Kim S, Cho E-J, Yoon H-G, Suh J-S, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
49. Pan DPJ, Senpan A, Caruthers SD, Williams TA, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids. Chem Commun 2009:3234-3236.
50. Pan D, Caruthers SD, Senpan A, Yalaz C, Stacy AJ, Hu G, Marsh JN, Gaffney PJ, Wickline SA, Lanza GM. Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus. J Am Chem Soc 2011, 133:9168-9171.
51. Wu HX, Zhang CX, Jin L, Yang H, Yang SP. Preparation and magnetic properties of cobalt nanoparticles with dendrimers as templates. Mater Chem Phys 2010, 121:342-348.
52. Pan DPJ, Caruthers SD, Senpan A, Schmieder AH, Wickline SA, Lanza GM. Revisiting an old friend: manganese-based MRI contrast agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:162-173.
53. Tu CQ, Ma XC, Pantazis P, Kauzlarich SM, Louie AY. Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages. J Am Chem Soc 2010, 132:2016-2023.
54. Tu CQ, Ma XC, House A, Kauzlarich SM, Louie AY. PET imaging and biodistribution of silicon quantum dots in mice. ACS Med Chem Lett 2011, 2:285-288.
55. Cherry SR, Louie AY, Jacobs RE. The integration of positron emission tomography with magnetic resonance imaging. Proc IEEE 2008, 96:416-438.
56. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
57. Tu CQ, Osborne EA, Louie AY. Activatable T (1) and T (2) magnetic resonance imaging contrast agents. Ann Biomed Eng 2011, 39:1335-1348.